Cargando…
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse
As the survival of patients with mantle cell lymphoma (MCL) continues to improve, patients are increasingly being treated with multiple regimens. However, outcome after each line remains poorly characterized in the modern era. To address this knowledge gap, we retrospectively studied 404 consecutive...
Autores principales: | Kumar, Anita, Sha, Fushen, Toure, Ahmed, Dogan, Ahmet, Ni, Andy, Batlevi, Connie L., Palomba, Maria Lia M., Portlock, Carol, Straus, David J., Noy, Ariela, Horwitz, Steven M., Moskowitz, Alison, Hamlin, Paul, Moskowitz, Craig H., Matasar, Matthew J., Zelenetz, Andrew D., Younes, Anas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527702/ https://www.ncbi.nlm.nih.gov/pubmed/31110172 http://dx.doi.org/10.1038/s41408-019-0209-5 |
Ejemplares similares
-
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
por: Batlevi, Connie L., et al.
Publicado: (2020) -
Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting
por: Zheng, Serena, et al.
Publicado: (2023) -
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
por: Bobillo, Sabela, et al.
Publicado: (2021) -
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
por: Sha, Fushen, et al.
Publicado: (2022) -
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
por: Intlekofer, Andrew M., et al.
Publicado: (2018)